Cargando…

TUFT1 Promotes Osteosarcoma Cell Proliferation and Predicts Poor Prognosis in Osteosarcoma Patients

OBJECTIVE: This study is aimed at exploring the role of TUFT1 in osteosarcomas. METHODS: We investigated the expression of TUFT1 in osteosarcoma cell lines and explored the correlation between TUFT1 expression and prognosis in osteosarcoma patients based on the expression data downloaded from Gene E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yao-Ping, He, Jian-Guo, Li, Ping, Qiu, Ning-Hui, Wang, Li-Jun, Feng, Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874716/ https://www.ncbi.nlm.nih.gov/pubmed/33817108 http://dx.doi.org/10.1515/biol-2018-0048

Ejemplares similares

LOXL1-AS1 predicts poor prognosis and promotes cell proliferation, migration, and invasion in osteosarcoma
por: Chen, Si, et al.
Publicado: (2019)

Long intergenic non-protein coding RNA 00460 predicts a poor prognosis and promotes tumorigenesis of human osteosarcoma
por: Jiang, Jian-Jun, et al.
Publicado: (2020)

Calponin 3 is associated with poor prognosis and regulates proliferation and metastasis in osteosarcoma
por: Dai, Fei, et al.
Publicado: (2020)

Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis
por: Li, Wei, et al.
Publicado: (2016)

The Cytoplasmic Expression Of CLDN12 Predicts An Unfavorable Prognosis And Promotes Proliferation And Migration Of Osteosarcoma
por: Tian, Xiaoqing, et al.
Publicado: (2019)

PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells
por: Li, Zhengjiang, et al.
Publicado: (2022)

Elevated Expression of miR-629 Predicts a Poor Prognosis and Promotes Cell Proliferation, Migration, and Invasion of Osteosarcoma
por: Li, Xuesen, et al.
Publicado: (2020)

Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis
por: Cheng, Dong-dong, et al.
Publicado: (2017)

Overexpression of BRINP3 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration via MAP4 in Osteosarcoma
por: Zeng, Wenchao, et al.
Publicado: (2022)

Overexpression of p62 is associated with poor prognosis and aggressive phenotypes in osteosarcoma
por: Lu, Yao, et al.
Publicado: (2018)

Increased DEF6 expression is correlated with metastasis and poor prognosis in human osteosarcoma
por: Zhang, Qiao, et al.
Publicado: (2020)

CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma
por: Ma, Chao, et al.
Publicado: (2019)

High expression of TRPM8 predicts poor prognosis in patients with osteosarcoma
por: Zhao, Wei, et al.
Publicado: (2016)

Highly expressed ribosomal protein L34 indicates poor prognosis in osteosarcoma and its knockdown suppresses osteosarcoma proliferation probably through translational control
por: Luo, Shuju, et al.
Publicado: (2016)

Long non-coding RNA XIST predicts poor prognosis and promotes malignant phenotypes in osteosarcoma
por: Wang, Wei, et al.
Publicado: (2019)

The lncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma
por: Zhang, Xuedong, et al.
Publicado: (2018)

Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients
por: Tang, Xue-Feng, et al.
Publicado: (2019)

Downregulation of microRNA-605 indicates poor prognosis and promotes the progression of osteosarcoma
por: Yi, Xiuling, et al.
Publicado: (2020)

STK39, overexpressed in osteosarcoma, regulates osteosarcoma cell invasion and proliferation
por: Huang, Tao, et al.
Publicado: (2017)

MiR-455-3p downregulation facilitates cell proliferation and invasion and predicts poor prognosis of osteosarcoma
por: Yi, Xijun, et al.
Publicado: (2020)

CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study
por: HE, AINA, et al.
Publicado: (2012)

Aberrant expression of SPAG6 and NM23 predicts poor prognosis of human osteosarcoma
por: Bao, Zhengqi, et al.
Publicado: (2022)

MiR-183-5p Promotes Tumor Progression of Osteosarcoma and Predicts Poor Prognosis in Patients
por: Jin, Lin, et al.
Publicado: (2021)

High Expression of HULC Is Associated with Poor Prognosis in Osteosarcoma Patients
por: Uzan, Vanessa Regina Maciel, et al.
Publicado: (2016)

LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma
por: Yun-Bo, Feng, et al.
Publicado: (2016)

CSE1L interaction with MSH6 promotes osteosarcoma progression and predicts poor patient survival
por: Cheng, Dong-dong, et al.
Publicado: (2017)

Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma
por: Li, Zhishuang, et al.
Publicado: (2015)

DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma
por: Wang, Lin, et al.
Publicado: (2017)

NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
por: Huang, Zhen, et al.
Publicado: (2021)

High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis
por: Zhu, Bin, et al.
Publicado: (2016)

Overexpression of carboxypeptidase X M14 family member 2 predicts an unfavorable prognosis and promotes proliferation and migration of osteosarcoma
por: Zhao, Xin, et al.
Publicado: (2019)

Polymeric immunoglobulin receptor expression is correlated with poor prognosis in patients with osteosarcoma
por: WANG, XUANWEI, et al.
Publicado: (2014)

Increased Six1 expression is associated with poor prognosis in patients with osteosarcoma
por: Chao, Lemeng, et al.
Publicado: (2017)

Upregulation of long-noncoding RNA PTPRG-AS1 can predict the poor prognosis and promote migration and invasion in patients with osteosarcoma
por: Ge, Rile, et al.
Publicado: (2021)

HER4 Promotes Osteosarcoma Progression and Predicts Poor Prognosis through the PTEN-PI3K/AKT Pathway
por: Ma, Kun, et al.
Publicado: (2022)

Factors Associated with Promoted Proliferation of Osteosarcoma by Peptidylarginine Deiminase 4
por: Guo, Jianping, et al.
Publicado: (2021)

Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
por: Huang, Zhen, et al.
Publicado: (2021)

Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma
por: Li, Mingzhe, et al.
Publicado: (2022)

Osteopontin as a biomarker for osteosarcoma therapy and prognosis
por: Han, Xingwen, et al.
Publicado: (2019)

Downregulation of miR-1826 Indicates a Poor Prognosis for Osteosarcoma Patients and Regulates Tumor Cell Proliferation, Migration, and Invasion
por: Li, Peng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mth1g0af1p6e2pj2s4lvqj4bfe